Despite repeated assertions by original equipment manufacturers that US FDA needs to impose quality and reporting requirements on third-party organizations that provide services and maintenance for medtech equipment, the agency said in a new report that “the current available evidence” does not justify extra rules.
“The objective evidence indicates that many OEMs and third-party entities provide high quality, safe and effective servicing of medical devices,”...